TSX News -
NFI announces fourth quarter and full year 2023 results
All figures quoted in U.S. dollars unless otherwise noted: 2023 Q4 revenue of $792 million; 1,227 equivalent units (“EUs”) delivered, […]
TSX News -
Stella-Jones Announces Fourth Quarter and Year-End Results
Annual sales of $3,319 million, up 8%, driven by 13% organic sales growth in infrastructure product categories Record increase in […]
Lithium Ionic Extends Payment Schedule for Acquisition of the Vale and Borges Claims
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Lithium Ionic Corp. (TSXV: LTH; OTCQX: LTHCF; FSE: H3N) (“Lithium Ionic” or the […]
Hemlo Explorers Announces Receipt of Final Tranche of OJEP Grant
TORONTO, Feb. 29, 2024 (GLOBE NEWSWIRE) — Hemlo Explorers Inc. (the “Company”) (TSXV: HMLO) is pleased to announce that it […]
Enviri Corporation Reports Fourth Quarter And Full Year 2023 Results
Fourth Quarter Revenues from Continuing Operations Totaled $529 Million, an Increase of 13 Percent Over the Prior-Year Quarter Q4 GAAP […]
Alta Equipment Group Announces Date of Fourth Quarter and Full Year 2023 Financial Results Release, Conference Call and Webcast
LIVONIA, Mich., Feb. 29, 2024 (GLOBE NEWSWIRE) — Alta Equipment Group Inc. (NYSE: ALTG) (“Alta” or the Company”), a leading […]
Green Thumb Expands Florida Retail Footprint with New RISE Dispensary in Dunnellon, its 15th Location in the Sunshine State
CHICAGO and VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) — RISE Dispensaries, a rapidly growing cannabis retail chain owned […]
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
GAITHERSBURG, Md., Feb. 29, 2024 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, March […]
Bath & Body Works Reports Fourth Quarter and Full-Year 2023 Results and Provides 2024 Outlook
Fourth Quarter and Full-Year Net Sales and Earnings Per Share Exceed Guidance Board of Directors Authorizes New Share Repurchase Program COLUMBUS, […]
ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance
Generated quarterly net revenues of $131.7 million, representing year-over-year growth of 39.7%, net income to common shareholders of $0.7 million, […]
